Back to Search Start Over

Autolus announces changes to its Board and Management Team

Source :
Legal Monitor Worldwide. August 5, 2020
Publication Year :
2020

Abstract

(GlobeNewswire) - Autolus Therapeutics plc(Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced the appointment of Dr. Jay T Backstrom to its Board of Directors, [...]

Subjects

Subjects :
Celgene Corp. -- Officials and employees
Daratumumab
Pharmaceutical industry -- Officials and employees
T cells
Business, international
Law

Details

Language :
English
Database :
Gale General OneFile
Journal :
Legal Monitor Worldwide
Publication Type :
News
Accession number :
edsgcl.631602217

Tools

Authors Abstract Subjects Details